Gain confidence, reassurance and control over your EU MDR strategy

Dr Gayle Buchel
A woman writing her own medical device regulation documentation

What if there was a way to save a portion of your regulatory budget by writing your own MDR technical documents? What if you could build your own technical file using proven frameworks and detailed templates, with step-by-step guidance from EU MDR experts?

EnableCE from Mantra Systems is a product suite created for medical device manufacturers who would like to take control of their own regulatory processes but are in need of training, support or guidance from regulatory specialists.

By building your own technical files within a guided framework, unnecessary financial outlays for comprehensive regulatory consulting packages can be minimised.

The cost of compliance

With increasing costs across the industry, the requirements to become EU MDR compliant can add significant expense to an already tight balance sheet. Afterall, transitioning to the MDR is costly — MedTech Europe estimates compliance costs of 8-15% of revenue from certified devices, which translates into £800K - £1.5M for an SME with revenues of £10M.

In the MedTech Europe report (commissioned by Innovate UK in September 2019), the readiness of UK small and medium size enterprise (SME) medical device companies for the Regulation (EU) 2017/745, commonly referred to as the EU Medical Device Regulation (MDR), was investigated.

In response to the survey, with less than one year to go to the date of application of the MDR, 60% of medical device manufacturers had not yet budgeted for the MDR. Of the 40% who had, only 12% had provisioned between 8-15% of their impacted sales revenues.

Regardless of the device classification, EU MDR compliance is a labour-intensive and expensive exercise. It requires significantly more in terms of clinical evidence, risk assessments, post market surveillance, supply chain obligations and data for the Unique Device Identification (UDI) system and the new EU Eudamed database.

EnableCE – saving you time and money

EnableCE was built to give the control of timelines and regulatory budgets back to the medical device manufacturer. Regardless of the degree of assistance you require, there is an EnableCE product for everyone.

Mantra Systems is well positioned to be your regulatory partner for Clinical Evaluation, guiding and supporting you while you complete your own MDR compliant technical file.

Please contact us if you have any questions about this article or would like to discuss our products and services in more detail.

Back to top

Related articles

  1. US and EU flags on poles alongside each other.

    Clinical Evidence under EU MDR: Leveraging FDA Clinical Data to Streamline EU MDR Compliance

    FDA approval alone is not sufficient for European market access - a theme we explore futher in this article and the accompanying webinar.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  2. An AI-generated image of 3 people in an office in front of a whiteboard with the words 'Medical Device Market Entry Strategy' written above a world map.

    EU MDR & NHS DTAC Cybersecurity Requirements for UK Market Entry

    This guest article from our partner Cyber Alchemy shows you how to build cybersecurity evidence for the EU MDR and NHS DTAC.

    Luke Hill Luke Hill Co-Founder of Cyber Alchemy
  3. An illustration showing a GPS-driven navigation route superimposed upon someone using a laptop.

    Where to Launch First? A MedTech Founder's Regulatory Roadmap to the EU, UK and US

    Cyber Alchemy × Mantra Systems — Episode 1: All three markets operate under different regulatory systems and place different demands on manufacturers.

    Ronghe Xu Ronghe Xu Regulatory Medical Writer & Strategic BD Lead China
  4. A woman uses an inhaler.

    Navigating EU MDR Article 117: A Practical Guide to Drug-Device Combination Product Submissions

    Implementation of the EU MDR 2017/745 has brought significant changes.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  5. Collage art showing a pair of binoculars, an analogy for surveillance.

    How EU MDR Post Market Surveillance differs from FDA post-market expectations

    We compare manufacturer-specific post-market obligations across both regulatory systems.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  6. An arrow arcs from the US over to Europe.

    How EU device classification differs from the US - Are you Prepared?

    Did you know an FDA Class II medical device could be immediately considered as a high-risk Class III device under European Union regulations?

    Gabriela Cardoso Gabriela Cardoso Regulatory Medical Writer
  7. A magnifying glass inspecting a number of wooden cubes with question marks upon them laid upon a blue table. The wooden cube under the magnifying glass has a lightbulb painted on it.

    Fixing the MDR and IVDR? The Commission’s Proposed Amendments and What They Mean for Manufacturers

    Exploring the key elements of this proposal.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  8. Two arms point at a sign and hold a question mark, in an abstract pop-art style.

    Regulatory Reset? The EU’s Proposed Changes to MDR and IVDR Explained

    Changes published in December 2025 aim to streamline EU medical device and in vitro diagnostics. We explain who is impacted and how.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  9. A pair of glasses rests on an eye test chart.

    Did You Know Your Glasses Were a Medical Device? A Regulatory Guide for Manufacturers

    The importance of correct classification and our recommended path to avoid common ophthalmic device 'gotchas'.

    Gabriela Cardoso Gabriela Cardoso Regulatory Medical Writer

More articles

Need help producing compliant CEPs & CERs? We are offering FREE CEPs to 5 qualifying applicants per week

Get your free CEP